Clinical Research Directory
Browse clinical research sites, groups, and studies.
68Ga-XHER2 PET/CT for HER2 Assessment
Sponsor: The First Affiliated Hospital of Xiamen University
Summary
The objective of this study is to evaluate the feasibility of 68Ga-XHER2 PET/CT as a noninvasive imaging approach for assessing HER2 expression in patients with solid tumors and to investigate the correlation between tracer uptake and pathological HER2 expression.
Official title: 68Ga-XHER2 PET/CT for Noninvasive Assessment of HER2 Expression Across Solid Tumors
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2026-10-22
Completion Date
2027-10-22
Last Updated
2026-10-21
Healthy Volunteers
Yes
Conditions
Interventions
68Ga-XHER2 PET/CT
Each participant will receive a single intravenous injection of 68Ga-XHER2, a novel HER2-targeted PET probe, followed by PET/CT imaging.
Locations (1)
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China